Aligos Therapeutics News

Piper Sandler Keeps Their Buy Rating on Aligos Therapeutics (ALGS)

TipRanksMay 17 05:27

Piper Sandler Sticks to Their Buy Rating for Aligos Therapeutics (ALGS)

TipRanksMay 8 06:10

Maintaining a Hold: Balancing Promise and Risk in Aligos Therapeutics' Clinical Pipeline

TipRanksMar 15 00:25

Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Structure Therapeutics, Inc. Sponsored ADR (GPCR) and Aligos Therapeutics (ALGS)

TipRanksMar 13 01:00

Piper Sandler Reaffirms Their Buy Rating on Aligos Therapeutics (ALGS)

TipRanksMar 8 06:45

Analysts Offer Insights on Healthcare Companies: Agilent (A), Cytokinetics (CYTK) and Aligos Therapeutics (ALGS)

TipRanksNov 22, 2023 05:40

Aligos Therapeutics (ALGS) Gets a Buy From Piper Sandler

TipRanksNov 17, 2023 06:56

Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcus Biosciences (RCUS), Aligos Therapeutics (ALGS) and Nektar Therapeutics (NKTR)

TipRanksNov 8, 2023 00:22

Piper Sandler Sticks to Its Buy Rating for Aligos Therapeutics (ALGS)

TipRanksNov 3, 2023 05:43

Aligos Therapeutics (ALGS) Receives a Buy From Piper Sandler

TipRanksAug 4, 2023 10:07

SVB Securities Remains a Hold on Aligos Therapeutics (ALGS)

TipRanksMay 5, 2023 10:31

SVB Securities Sticks to Its Hold Rating for Aligos Therapeutics (ALGS)

TipRanksMar 13, 2023 00:51

Piper Sandler Sticks to Its Buy Rating for Aligos Therapeutics (ALGS)

TipRanksJan 17, 2023 06:30

Aligos Therapeutics Analyst Ratings

Benzinga Analyst RatingsJan 17, 2023 05:31

Piper Sandler Maintains Overweight on Aligos Therapeutics, Raises Price Target to $7

Benzinga Real-time NewsJan 17, 2023 05:31

Piper Sandler: Raise the target price of Aligos Therapeutics (ALGS.US) to $7 to maintain the “increase in holdings” rating

Zhitong FinanceJan 17, 2023 01:36

SVB Securities Sticks to Its Hold Rating for Aligos Therapeutics (ALGS)

TipRanksJan 15, 2023 23:20

Aligos Therapeutics Analyst Ratings

Benzinga Analyst RatingsJan 6, 2023 04:26

SVB Securities Adjusts Aligos Therapeutics' Price Target to $2 From $3, Keeps Market Perform Rating

MT NewswiresNov 3, 2022 12:16

SVB Securities Remains a Hold on Aligos Therapeutics (ALGS)

TipRanksNov 3, 2022 07:40